QA: G1 Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001560241_2024_G1_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001560241, G1 Therapeutics Inc

  xvar xval
0 AssetsCurrent 114,948,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,476,000
3 remainder_Assets 5,116,000
4 LiabilitiesCurrent 29,716,000
5 LiabilitiesNoncurrent 4,381,000
6 remainder_Liabilities 52,057,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense -118,446
9 ResearchAndDevelopmentExpense 36,076,816
10 remainder_Expenses 34,612,173
11 remainder_Revenues 79,508,980
12 remainder_NetIncome -4,662,486
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 121,540,000
1 Liabilities 86,154,000
2 Expenses 70,570,543
3 Revenues 79,508,980
4 StockholdersEquity 35,386,000
5 NetIncome 4,275,951
6 ComprehensiveNetIncome 4,275,951
7 BaseVar 181,218,004
8 EconomicCapitalRatiobeforeLimitedLiability 0.784
9 EconomicCapitalRatio 2.13

Edgar->Model Mapping

Feature Distribution

Change over Time